Nanjing Vazyme Biotech Co., Ltd. (688105.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.53B |
| Enterprise Value | 6.54B |
| P/E Ratio | -522.56 |
| PEG Ratio | 11.21 |
| Price/Sales Ratio | 6.27 |
| Price/Book Ratio | 1.89 |
| Enterprise/Revenue | 6.32 |
| Enterprise/EBITDA | 275.12 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | -0.03 |
AD
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0 |
Income Statement
| Revenue | 1.38B |
| Revenue/Share | 3.38 |
| Gross Profit | -40.48M |
| EBITDA | 56.88M |
| Net Income | -16.97M |
| Diluted EPS | -0.04 |
Balance Sheet
| Total Cash | 2.94B |
| Total Cash/Share | 7.03 |
| Total Debt | 972M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 3.39 |
| Book Value Per Share | 9.07 |
Price History
| 52-Week Change | 2.94 |
| 52-Week High | 20.59 |
| 52-Week Low | 12.89 |
| Moving Average 50 Days | 14.92 |
| Moving Average 200 Days | 16.11 |
Statistics
| Average Volume | 3.06M |
| Shares Outstanding | 516.99M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 2.92 |
| Payout Ratio | -5.13 |
| Last Split Factor | 13:10 |
| Last Split Date | June 03, 2026 |
AD
